Overall population (n = 79) | No AF (n = 63) | AF (n = 16) | P value |
---|---|---|---|
LV systolic parameters | |||
LVEF (%) | 61 [51–69] | 66 [53–70] | 0.37 |
LV end diastolic volume (ml) | 109 [74–129] | 109 [90–156] | 0.50 |
LV end systolic volume (ml) | 43 [26–58] | 38 [24–65] | 0.85 |
Stroke volume index (ml/m2) | 33 [26–39] | 27 [24–35] | 0.12 |
Cardiac index (l/min/m2) | 2.49 [1.98–3.23] | 2.15 [1.78–3.01] | 0.24 |
LV diastolic functional parameters | |||
E wave (cm s−1) | 84 [69–92] | 77 [65–98] | 0.60 |
A wave (cm s−1) | 83 [68–105] | 74 [61–100] | 0.63 |
E/A ratio | 0.9 [0.74–1.2] | 0.8 [0.7–1.2] | 0.74 |
Lateral E/e’ | 8.5 [6.3–10.4] | 9.7 [7.4–12.0] | 0.24 |
E wave deceleration time (ms) | 250 [180–309] | 254[190–304] | 0.93 |
LA volume (ml) | 49 [39–58] | 56 [32–67] | 0.52 |
LA volume index (ml/m2) | 23 [18–27] | 28 [16–38] | 0.19 |
RV Parameters | |||
RV basal dimension (mm) | 46 [40–51] | 43 [41–50] | 0.72 |
RV mid-cavity dimension (mm) | 34 [29.40] | 32 [26–39] | 0.38 |
RV longitudinal dimension (mm) | 77 [71–82] | 74 [71–78] | 0.42 |
RV EDA (cm2) | 20 [15–25] | 18 [16–21] | 0.37 |
RV ESA (cm2) | 11 [7–15] | 9 [8–11] | 0.18 |
RA volume indexed to BSA (ml/m2) | 21 [14–25] | 19 [15–25] | 0.95 |
RV systolic function parameters | |||
TAPSE (mm) | 24.2 [21.0–28] | 21.5 [18.2–24.1] | 0.6 |
RV- S’ (cm/s-1) | 16.0 [13.4–19.4] | 18.0 [16.3–20.0] | 0.43 |
RV FAC (%) | 47 [38–53] | 49 [46–53] | 0.23 |
Pericardial effusion (> 10 mm) | 3 (5) | 2 (12) | 0.26 |
Valvular heart disease | 2 (3)† | 1 (6)* | 0.10 |
LA strain parameters | |||
LASr (%) | 30.5 [23.8–36.2] | 20.2 [12.3–27.3] | 0.002 |
LAScd (%) | − 17.2 [(− 5.0)–(− 10.2)] | − 8.1 [(− 6.3)–(− 10.9)] | < 0.001 |
LASct (%) | − 13.3 [(− 7.7)–(− 16.9)] | − 9.7 [(− 5.2)–(− 16.1)] | 0.31 |